Research Article
Impact of Zinc to Copper Ratio and Lipocalin 2 in Obese Patients Undergoing Sleeve Gastrectomy
Table 4
Copper (Cu), zinc (Zn), ceruloplasmin (Cp), and Zn-to-Cu ratio in the control group and groups with morbid obesity (MO).
(a) |
| | Cu (μg/dL) | value | Zn (μg/dL) | value | Preoperative | Postoperative | Preoperative | Postoperative |
| Control group | | — | | | — | | Group A | | | 0.085 | | | 0.003 | Group B | | | 0.066 | | | 0.104 | Group C | | | 0.145 | | 9 | 0.098 | ANOVA value | 21.3 0.001 | 5.21 0.031 | | 26.5 0.001 | 5.04 0.039 | |
|
|
(b) |
| | Zn-to-Cu ratio | value | Ceruloplasmin (mg/dL) | value | Preoperative | Postoperative | Preoperative | Postoperative |
| Control group | | — | | | — | | Group A | | | 0.041 | | | 0.069 | Group B | | | 0.526 | | | 0.104 | Group C | | | 0.023 | | | 0. 21 | ANOVA value | 6.01 0.029 | 2.85 0.141 | | 2.07 0.331 | 1.68 0.411 | |
|
|
Morbid obesity (MO) groups: Groups A, B, and C.
|